The Procter & Gamble Company (NYSE:PG)
Market Cap | 350.48B |
---|---|
Revenue | 80.19B |
Gross Profit | 38.03B |
Shares Out | 2.39B |
EPS (ttm) | 5.7 |
PE Ratio | 24.2359 |
Forward PE | 24.7004 |
Dividend Rate (ttm) | 3.5348 |
Dividend Yield | 0.0241 |
Trading Day | Aug 12 |
---|---|
Last Price | $146.67 |
Previous Close | $145.26 |
Change ($) | 1.41 |
Change (%) | 0.97% |
Day's Open | 145.85 |
Day's Range | 144.96 - 146.73 |
Day's Volume | 5.04M |
52 Week Range | 128.66 - 163.84 |
About P&G
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.
NYSE:PG stock is currently trading at $146.67 as of 08:03 PM UTC, Aug 12, 2022. If you're interested in becoming an investor, read our detailed guide to investing in P&G stock.
Quick info
Cincinnati
Ohio
45202-3315
News
The Procter & Gamble Company earnings reports (2020)
Q3 2020 | Q2 2020 | Q1 2020 | |
---|---|---|---|
Actual EPS | 1.63 | 1.16 | 1.17 |
Consensus EPS | 1.42 | 1.01 | 1.13 |
Announce Time | BTO | BTO | BTO |
Number of Estimates | 17 | 18 | 17 |
EPS Surprise Dollar | 0.21 | 0.15 | 0.04 |
EPS Report Date | 20-10-2020 | 30-07-2020 | 17-04-2020 |
Fiscal End Date | 30-09-2020 | 30-06-2020 | 31-03-2020 |
Year Ago | 1.37 | 1.1 | 1.06 |
Year Ago % Change | 18.98% | 5.45% | 10.38% |
The Procter & Gamble Company earnings reports (2019)
Q4 2019 | Q3 2019 | Q2 2019 | |
---|---|---|---|
Actual EPS | 1.42 | 1.37 | 1.1 |
Consensus EPS | 1.37 | 1.24 | 1.05 |
Announce Time | BTO | BTO | BTO |
Number of Estimates | 17 | 19 | 20 |
EPS Surprise Dollar | 0.05 | 0.13 | 0.05 |
EPS Report Date | 23-01-2020 | 22-10-2019 | 30-07-2019 |
Fiscal End Date | 31-12-2019 | 30-09-2019 | 30-06-2019 |
Year Ago | 1.25 | 1.12 | 0.94 |
Year Ago % Change | 13.6% | 22.32% | 17.02% |
The Procter & Gamble Company income statements (2020) (USD)
October 2020 | September 2020 | June 2020 | March 2020 | |
---|---|---|---|---|
Total Revenue | 19.32B | 19.32B | 17.70B | 17.21B |
Cost of Revenue | 9.14B | 9.14B | 8.66B | 8.52B |
Gross Profit | 10.18B | 10.18B | 9.04B | 8.70B |
Research & Development | 0 | N.A | N.A | N.A |
Selling General & Admin | 4.90B | N.A | N.A | N.A |
Operating Expense | 14.04B | 14.12B | 14.10B | 13.69B |
Operating Income | 5.28B | 5.20B | 3.60B | 3.52B |
Other Income Expense Net | 0 | 100M | -135M | -26M |
EBIT | 5.28B | 5.20B | 3.60B | 3.52B |
Interest Income | 126M | 143M | 353M | N.A |
Pretax Income | 5.30B | 5.30B | 3.46B | 3.50B |
Income Tax | 0.99B | 0.99B | 675M | 541M |
Minority Interest | 31M | 31M | -14M | 40M |
Net Income | 4.21B | 4.28B | 2.80B | 2.92B |
Net Income Basic | 4.21B | 4.21B | 2.73B | 2.85B |
The Procter & Gamble Company income statements (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Total Revenue | 18.24B | 17.80B | 17.09B | 16.46B |
Cost of Revenue | 8.81B | 8.65B | 8.71B | 8.34B |
Gross Profit | 9.43B | 9.15B | 8.39B | 8.12B |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | 13.57B | 13.32B | 13.61B | 13.19B |
Operating Income | 4.67B | 4.48B | 3.48B | 3.27B |
Other Income Expense Net | -135M | -136M | -8.55B | 10M |
EBIT | 4.67B | 4.48B | 3.48B | 3.27B |
Interest Income | 185M | 198M | 176M | 152M |
Pretax Income | 4.53B | 4.34B | -5.07B | 3.28B |
Income Tax | 789M | 726M | 172M | 502M |
Minority Interest | 26M | 24M | 4M | 31M |
Net Income | 3.72B | 3.59B | -5.24B | 2.75B |
Net Income Basic | 3.65B | 3.53B | -5.31B | 2.68B |
The Procter & Gamble Company income statements (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Total Revenue | 17.44B | 16.69B | 16.50B | 16.28B |
Cost of Revenue | 8.78B | 8.42B | 8.56B | 8.21B |
Gross Profit | 8.66B | 8.27B | 7.94B | 8.07B |
Research & Development | N.A | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A | N.A |
Operating Expense | 13.38B | 13B | 13.39B | 12.66B |
Operating Income | 4.06B | 3.69B | 3.11B | 3.62B |
Other Income Expense Net | -143M | 252M | -822M | -371M |
EBIT | 4.06B | 3.69B | 3.11B | 3.62B |
Interest Income | 180M | 105M | 136M | 133M |
Pretax Income | 3.92B | 3.94B | 2.29B | 3.25B |
Income Tax | 700M | 729M | 399M | 713M |
Minority Interest | 22M | 12M | -1M | 29M |
Net Income | 3.19B | 3.20B | 1.89B | 2.51B |
Net Income Basic | 3.13B | 3.13B | 1.82B | 2.44B |
The Procter & Gamble Company income statements (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Total Revenue | 17.40B | 16.65B | 16.08B |
Cost of Revenue | 8.56B | 8.11B | 8.12B |
Gross Profit | 8.83B | 8.54B | 7.96B |
Research & Development | N.A | N.A | N.A |
Selling General & Admin | N.A | N.A | N.A |
Operating Expense | 13.24B | 12.76B | 12.96B |
Operating Income | 4.16B | 3.89B | 3.12B |
Other Income Expense Net | -123M | -140M | -188M |
EBIT | 4.16B | 3.89B | 3.12B |
Interest Income | 122M | 115M | 116M |
Pretax Income | 4.03B | 3.75B | 2.93B |
Income Tax | 1.47B | 881M | 725M |
Minority Interest | 66M | 17M | -13M |
Net Income | 2.50B | 2.85B | 2.22B |
Net Income Basic | 2.43B | 2.79B | 2.15B |
The Procter & Gamble Company balance sheet (2020) (USD)
October 2020 | September 2020 | June 2020 | March 2020 | |
---|---|---|---|---|
Current Cash | 13.39B | 13.39B | 16.18B | 15.39B |
Receivables | 5.04B | 5.04B | 4.18B | 4.64B |
Inventory | 5.71B | 5.71B | 5.50B | 5.33B |
Current Assets | 26.03B | 26.03B | 27.99B | 27.14B |
Other Current Assets | 1.88B | 1.88B | 2.13B | 1.78B |
Short Term Investments | 1.88B | N.A | N.A | N.A |
Long Term Investments | 93.87B | 66M | 67M | 50M |
Property/Plant Equipment | 20.88B | 20.88B | 21.54B | 21.31B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 23.81B | 23.81B | 23.79B | 23.83B |
Tangible Assets (Net) | -17.09B | -62.62B | -62.8B | -63.16B |
Other Assets | 8.61B | 8.55B | 7.41B | 6.61B |
Total Assets | 119.90B | 119.90B | 120.70B | 118.56B |
Accounts Payable | 11.94B | 11.94B | 12.07B | 10.46B |
Other Current Liabilities | 10.37B | 10.37B | 8.79B | 9.49B |
Total Current Liabilities | 30.01B | 30.01B | 32.98B | 32.90B |
Total Liabilities | 71.72B | 71.32B | 73.82B | 72.62B |
Long Term Debt | 23.95B | 23.95B | 24.19B | 23.96B |
Current Long Term Debt | 7.71B | N.A | 2.51B | N.A |
Minority Interest | 394M | 31M | -14M | 40M |
Common Stock | 68.48B | 2.48B | 2.48B | 2.48B |
Treasury Stock | -106.79B | 106.79B | 105.57B | 105.82B |
Retained Earnings | 102.54B | 102.54B | 100.24B | 99.47B |
Capital Surplus | N.A | 64.47B | 64.19B | 63.98B |
Shareholder Equity | 48.18B | 48.18B | 46.52B | 45.54B |
Other Liabilities | N.A | N.A | N.A | N.A |
The Procter & Gamble Company balance sheet (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Current Cash | 6.28B | 9.30B | 4.24B | 2.74B |
Receivables | 5.20B | 5.14B | 4.95B | 5.20B |
Inventory | 5.52B | 5.47B | 5.02B | 5.36B |
Current Assets | 18.92B | 21.93B | 22.47B | 22.31B |
Other Current Assets | 1.92B | 2.01B | 2.22B | 1.93B |
Short Term Investments | N.A | N.A | 6.05B | 7.09B |
Long Term Investments | 64M | 62M | 169M | 165M |
Property/Plant Equipment | 22.15B | 21.79B | 21.27B | 20.99B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 23.98B | 24B | 24.22B | 25.84B |
Tangible Assets (Net) | -63.99B | -62.08B | -70.84B | -69.61B |
Other Assets | 6.61B | 6.68B | 6.69B | 5.61B |
Total Assets | 111.72B | 114.06B | 115.10B | 121.67B |
Accounts Payable | 10.78B | 10.95B | 11.26B | 10.21B |
Other Current Liabilities | 9.98B | 9.69B | 8.71B | 9.25B |
Total Current Liabilities | 30.16B | 30.25B | 30.01B | 28.37B |
Total Liabilities | 65.82B | 67.07B | 67.52B | 66.12B |
Long Term Debt | 19.66B | 20.79B | 20.40B | 21.36B |
Current Long Term Debt | N.A | N.A | 3.39B | N.A |
Minority Interest | 26M | 24M | 4M | 31M |
Common Stock | 2.47B | 2.49B | 2.50B | 2.51B |
Treasury Stock | 105.76B | 102.51B | 100.41B | 99.48B |
Retained Earnings | 98.41B | 96.63B | 94.92B | 102.10B |
Capital Surplus | 64.02B | 63.95B | 63.83B | 63.62B |
Shareholder Equity | 45.54B | 46.58B | 47.19B | 55.07B |
Other Liabilities | N.A | N.A | N.A | N.A |
The Procter & Gamble Company balance sheet (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Current Cash | 3.70B | 2.55B | 2.57B | 5.33B |
Receivables | 5.06B | 5.04B | 4.69B | 5.15B |
Inventory | 5.28B | 5.18B | 4.74B | 5.21B |
Current Assets | 24.43B | 23.35B | 23.32B | 27.96B |
Other Current Assets | 1.98B | 1.88B | 2.05B | 2.07B |
Short Term Investments | 8.42B | 8.71B | 9.28B | 10.21B |
Long Term Investments | 163M | 158M | 141M | 124M |
Property/Plant Equipment | 20.82B | 20.59B | 20.60B | 20.93B |
Good Will | N.A | N.A | N.A | N.A |
Intangible Assets | 25.95B | 23.92B | 23.90B | 24.13B |
Tangible Assets (Net) | -71.07B | -67.32B | -68.32B | -67.29B |
Other Assets | 5.39B | 5.20B | 5.17B | 5.06B |
Total Assets | 123.69B | 118.44B | 118.31B | 124.37B |
Accounts Payable | 10.27B | 10.24B | 10.34B | 9.72B |
Other Current Liabilities | 8.87B | 8.47B | 7.20B | 8.13B |
Total Current Liabilities | 31.25B | 29.22B | 28.24B | 30.71B |
Total Liabilities | 69.24B | 65.94B | 65.43B | 69.42B |
Long Term Debt | 21.51B | 20.78B | 20.86B | 22.44B |
Current Long Term Debt | N.A | N.A | 1.77B | N.A |
Minority Interest | 22M | 12M | -1M | 29M |
Common Stock | 2.50B | 2.49B | 2.50B | 2.51B |
Treasury Stock | 99.48B | 99.96B | 99.22B | 97.91B |
Retained Earnings | 101.17B | 99.83B | 98.64B | 98.62B |
Capital Surplus | 63.68B | 63.71B | 63.85B | 63.72B |
Shareholder Equity | 53.99B | 52.24B | 52.29B | 54.32B |
Other Liabilities | N.A | N.A | N.A | N.A |
The Procter & Gamble Company balance sheet (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Current Cash | 7.43B | 5.02B | 5.57B |
Receivables | 5.18B | 4.94B | 4.59B |
Inventory | 5.13B | 5.02B | 4.62B |
Current Assets | 31.21B | 28.10B | 26.49B |
Other Current Assets | 2.14B | 2.12B | 2.14B |
Short Term Investments | 11.33B | 10.98B | 9.57B |
Long Term Investments | 115M | 132M | 132M |
Property/Plant Equipment | 20.42B | 20.11B | 19.89B |
Good Will | N.A | N.A | N.A |
Intangible Assets | 24.22B | 24.26B | 24.19B |
Tangible Assets (Net) | -66.4B | -64.78B | -64.46B |
Other Assets | 5.05B | 5.06B | 5B |
Total Assets | 126.64B | 122.85B | 120.41B |
Accounts Payable | 9.74B | 9.46B | 9.63B |
Other Current Liabilities | 7.82B | 7.24B | 6.58B |
Total Current Liabilities | 33.11B | 30.72B | 30.21B |
Total Liabilities | 71.92B | 67.44B | 64.63B |
Long Term Debt | 22.19B | 20.19B | 18.04B |
Current Long Term Debt | N.A | N.A | 1.68B |
Minority Interest | 66M | 17M | -13M |
Common Stock | 2.52B | 2.54B | 2.55B |
Treasury Stock | 97.12B | 95.56B | 93.72B |
Retained Earnings | 97.88B | 97.20B | 96.12B |
Capital Surplus | 63.76B | 63.71B | 63.64B |
Shareholder Equity | 54.11B | 54.82B | 55.18B |
Other Liabilities | N.A | N.A | N.A |
The Procter & Gamble Company cash flow (2020) (USD)
October 2020 | September 2020 | June 2020 | March 2020 | |
---|---|---|---|---|
Net Income | 4.21B | 4.28B | 2.80B | 2.92B |
Depreciation | 671M | 671M | 814M | 799M |
Changes in Receivables | 865M | -865M | 462M | 556M |
Changes in Inventories | 209M | -137M | -104M | N.A |
Cash Change | -2.79B | -2.79B | 788M | 9.11B |
Cash Flow | 4.74B | 4.74B | 4.81B | 4.06B |
Capital Expenditures | -850M | -850M | -658M | -731M |
Investments | N.A | N.A | -3M | -3M |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | 829M | -829M | -659M | -725M |
Dividends Paid | N.A | -2.03B | -2.03B | -1.91B |
Net Borrowings | 16.38B | -3.59B | -1.59B | 8.05B |
Other Financing Cash Flows | N.A | N.A | N.A | N.A |
Cash Flow Financing | -6.73B | -6.73B | -3.4B | 5.95B |
Exchange Rate Effect | N.A | 31M | 40M | -170M |
The Procter & Gamble Company cash flow (2019) (USD)
December 2019 | September 2019 | June 2019 | March 2019 | |
---|---|---|---|---|
Net Income | 3.72B | 3.59B | -5.24B | 2.75B |
Depreciation | 677M | 723M | 820M | 711M |
Changes in Receivables | -53M | -192M | 247M | -143M |
Changes in Inventories | 16M | -549M | 362M | -70M |
Cash Change | -3.03B | 5.07B | 1.50B | -0.96B |
Cash Flow | 4.36B | 4.17B | 4.15B | 3.52B |
Capital Expenditures | -605M | -1.08B | -814M | -752M |
Investments | N.A | 6.15B | 1.09B | 1.42B |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -650M | 5.08B | 647M | 573M |
Dividends Paid | -1.92B | -1.93B | -1.94B | -1.86B |
Net Borrowings | -1.55B | -61M | -351M | -3.06B |
Other Financing Cash Flows | N.A | N.A | N.A | N.A |
Cash Flow Financing | -6.8B | -4.12B | -3.3B | -5.07B |
Exchange Rate Effect | 56M | -65M | 7M | 18M |
The Procter & Gamble Company cash flow (2018) (USD)
December 2018 | September 2018 | June 2018 | March 2018 | |
---|---|---|---|---|
Net Income | 3.19B | 3.20B | 1.89B | 2.51B |
Depreciation | 650M | 643M | 750M | 716M |
Changes in Receivables | -20M | -349M | 463M | 33M |
Changes in Inventories | -37M | -494M | 269M | N.A |
Cash Change | 1.15B | -24M | -2.76B | -2.11B |
Cash Flow | 4.01B | 3.57B | 4.20B | 3.35B |
Capital Expenditures | -701M | -1.08B | -0.91B | -0.91B |
Investments | 458M | 443M | 0.98B | 0.97B |
Investing Activity (other) | N.A | N.A | N.A | N.A |
Total Investing Cash Flows | -3.85B | -865M | 97M | 97M |
Dividends Paid | -1.85B | -1.85B | -1.86B | -1.81B |
Net Borrowings | 2.57B | 24M | -3.65B | -2.9B |
Other Financing Cash Flows | N.A | N.A | N.A | N.A |
Cash Flow Financing | 1.03B | -2.66B | -6.86B | -5.64B |
Exchange Rate Effect | -43M | -70M | -192M | 82M |
The Procter & Gamble Company cash flow (2017) (USD)
December 2017 | September 2017 | June 2017 | |
---|---|---|---|
Net Income | 2.50B | 2.85B | 2.22B |
Depreciation | 676M | 692M | 720M |
Changes in Receivables | -240M | -348M | -236M |
Changes in Inventories | -100M | -357M | 216M |
Cash Change | 2.41B | -545M | 626M |
Cash Flow | 3.68B | 3.63B | 3.69B |
Capital Expenditures | -768M | -1.13B | -1.15B |
Investments | -383M | -1.52B | 2M |
Investing Activity (other) | N.A | N.A | N.A |
Total Investing Cash Flows | -1.17B | -2.53B | -0.99B |
Dividends Paid | -1.81B | -1.82B | -1.83B |
Net Borrowings | 3.29B | 2.02B | 222M |
Other Financing Cash Flows | N.A | N.A | N.A |
Cash Flow Financing | -152M | -1.72B | -2.23B |
Exchange Rate Effect | 47M | 82M | 159M |
The Procter & Gamble Company dividends (USD)
Ex date | Payment date | Record date | Declared date | Amount | Description | Frequency |
---|---|---|---|---|---|---|
22-10-2020 | 16-11-2020 | 23-10-2020 | N.A | 0.79 | Ordinary Shares | Quarterly |
23-07-2020 | 17-08-2020 | 24-07-2020 | N.A | 0.79 | Ordinary Shares | Quarterly |
23-04-2020 | 15-05-2020 | 24-04-2020 | N.A | 0.79 | Ordinary Shares | Quarterly |
23-01-2020 | 18-02-2020 | 24-01-2020 | N.A | 0.75 | Ordinary Shares | Quarterly |
17-10-2019 | 15-11-2019 | 18-10-2019 | N.A | 0.75 | Ordinary Shares | Quarterly |
18-07-2019 | 15-08-2019 | 19-07-2019 | N.A | 0.75 | Ordinary Shares | Quarterly |
17-04-2019 | 15-05-2019 | 19-04-2019 | N.A | 0.75 | Ordinary Shares | Quarterly |
17-01-2019 | 15-02-2019 | 18-01-2019 | N.A | 0.72 | Ordinary Shares | Quarterly |
18-10-2018 | 15-11-2018 | 19-10-2018 | N.A | 0.72 | Ordinary Shares | Quarterly |
19-07-2018 | 15-08-2018 | 20-07-2018 | N.A | 0.72 | Ordinary Shares | Quarterly |
19-04-2018 | 15-05-2018 | 20-04-2018 | N.A | 0.72 | Ordinary Shares | Quarterly |
18-01-2018 | 15-02-2018 | 19-01-2018 | N.A | 0.69 | Ordinary Shares | Quarterly |
19-10-2017 | 15-11-2017 | 20-10-2017 | N.A | 0.69 | Ordinary Shares | Quarterly |
19-07-2017 | 15-08-2017 | 21-07-2017 | N.A | 0.69 | Ordinary Shares | Quarterly |
19-04-2017 | 15-05-2017 | 21-04-2017 | N.A | 0.69 | Ordinary Shares | Quarterly |
18-01-2017 | 15-02-2017 | 20-01-2017 | N.A | 0.67 | Ordinary Shares | Quarterly |
19-10-2016 | 15-11-2016 | 21-10-2016 | N.A | 0.67 | Ordinary Shares | Quarterly |
20-07-2016 | 15-08-2016 | 22-07-2016 | N.A | 0.67 | Ordinary Shares | Quarterly |
14-04-2016 | 16-05-2016 | 18-04-2016 | N.A | 0.67 | Ordinary Shares | Quarterly |
20-01-2016 | 16-02-2016 | 22-01-2016 | N.A | 0.66 | Ordinary Shares | Quarterly |
21-10-2015 | 16-11-2015 | 23-10-2015 | N.A | 0.66 | Ordinary Shares | Quarterly |
22-07-2015 | 17-08-2015 | 24-07-2015 | N.A | 0.66 | Ordinary Shares | Quarterly |
Total Valuation
Procter & Gamble Co. has a market cap or net worth of $350.48 billion. The enterprise value is $374.75 billion.
Important Dates
Share Statistics
Procter & Gamble Co. has 2.39 billion shares outstanding.
Valuation Ratios
The trailing PE ratio is 24.2359 and the forward PE ratio is 24.7004. Procter & Gamble Co.'s PEG ratio is 4.3691.
Stock Price Statistics
The stock price has decreased by -0.0876%. The beta is 0.4018, so Procter & Gamble Co.'s price volatility has been lower than the market average.
Income Statement
In the last 12 months, Procter & Gamble Co. had revenue of $80.19 billion and earned $38.03 billion in profits. Earnings per share was $5.7.